View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
March 22, 2005

MIV Therapeutics receives government grant for coating technology research

Canadian pharmaceutical coating developer MIV Therapeutics has received a government grant for a research program focused on the development of new drug coatings for cardiovascular stents, tubular structures of stainless steel or plastic used to prevent bodily tubes from becoming blocked by disease.

By CBR Staff Writer

According to the company’s subsidiary, MIVI Technologies, the National Research Council approved its application after an in depth familiarization with technologies proposed by the unit and a review of the company’s organizational and fiscal capability to carry on with the proposed $1m plus R&D program.

Approval of our application comes at a time when the company is gearing towards clinical trials of its proprietary Hydroxyapatite (HAp) nano-coating technology, and when we are simultaneously aggressively pursuing the development of the next generation of fully biocompatible coating for a variety of applications on medical devices, said Alan Lindsay, CEO of MIV Therapeutics. IRAP funding will provide welcome support to these corporate development strategies.

Arc Rajtar, who heads the MIVI R&D team, said the funding will be used to support personnel in their attempts to meet the objectives of the program. He added that the multilayer composite coatings will offer drug release characteristics which can be engineered to accommodate a broad variety of drugs and their specific applications, in a manner which is demanded by the medical practitioners.

Content from our partners
Rethinking cloud: challenging assumptions, learning lessons
DTX Manchester welcomes leading tech talent from across the region and beyond
The hidden complexities of deploying AI in your business

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.